Overview
Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy
Status:
Completed
Completed
Trial end date:
2010-01-01
2010-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study will evaluate bleeding risk and differences in outcomes in patients receiving and not receiving anticoagulant or antiplatelet therapyAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Pain Management Center of PaducahTreatments:
Anticoagulants
Platelet Aggregation Inhibitors
Criteria
Inclusion Criteria:- Subjects undergoing interventional techniques. Subjects who were able to give
voluntary, written informed consent.
Exclusion Criteria:
- All those things, patients on heparin, dextran, and low molecular heparin